Medicare’s Hospital Value-Based Purchasing program has not accelerated the improvement of patient experience beyond previous trends, according to a study reported this week in Health Affairs. “Instead, we found that the rate of improvements in patient experience has slowed since the program was implemented,” the authors said. “Over the entire study period, certain subsets of hospitals (such as small ones) seemed to have improved in patient experience more than other subsets (such as larger hospitals), yet even for the institutions that had greater improvement, the majority of the change occurred before implementation of the VBP program.” The study examined trends in multiple measures of patient satisfaction between 2008 and 2014. The Centers for Medicare & Medicaid Services began publicly reporting on patient-reported experience through the Hospital Consumer Assessment of Healthcare Providers and Systems survey in 2008, and tied Medicare payments directly to these measures through the VBP program in 2011. The authors said the study “adds to a growing body of literature suggesting that U.S. pay-for-performance schemes have had little to no effect on driving meaningful improvements in other patient outcomes.”

Related News Articles

Headline
In a new “Safety Speaks” conversation, Harry S. Smith, board chair of Valley Health System and member of the AHA Committee on Governance, discusses how Valley…
Headline
The Healthcare Equality Network July 3 sent a letter to the Centers for Medicare & Medicaid Services, expressing concerns about claims denials by…
Headline
The Department of Health and Human Services’ Office of Inspector General last week announced its intent to investigate Medicare Advantage Organizations’ prior…
Headline
In a letter submitted July 2 to the Centers for Medicare & Medicaid Services on guidance for the Medicare Drug Price Negotiation Program, the AHA expressed…
Headline
The Centers for Medicare & Medicaid Services June 28 released a proposed rule on mitigating the impact of significant, anomalous and highly suspect (SAHS)…
Headline
The Department of Health and Human Services June 26 announced beneficiary coinsurance reductions for 64 prescription drugs available through Medicare Part B.…